CAH vs CGNX · P/E 35, rev $254.25B vs P/E 76, rev $291.3M
Cardinal Health Inc (CAH) versus Cognex Corporation (CGNX) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Cognex Corporation (CGNX) is a scientific & technical instruments company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CGNX revenue for 2026-07-05 was $291.3M. Net income was $72.8M. Revenue was up 8.5% from 2026-04-05 to 2026-07-05. CGNX currently screens at market cap $10.78B and trailing P/E 76.2.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CGNX currently screens at market cap $10.78B and trailing P/E 76.2.
Not investment advice. Open the CAH and CGNX stock pages for the full models.
Not investment advice.